Figure 2: The pattern of the 3-(2-deoxy-β-D-erythro-pentafuranosyl) pyrimido[1,2-α]purin-10(3H)-one deoxyguanosine adduct-spot in the liver of a C57BL/6 mice, that developed an experimental non-alcoholic steatohepatitis after eight weeks of high-fat and cholesterol diet feed (A) and in the liver of a control mice (B).